Roche Molecular Systems

https://molecular.roche.com/news/roche-receives-clia-waiver-for-cobas-influenza-ab-rsv-test-for-the-cobas-liat/

Roche receives CLIA waiver for cobas® Influenza A/B & RSV test for the cobas® Liat® The first CLIA-waived, real-time PCR test that differentiates flu and RSV in 20 minutes is available now for use in physician offices and urgent care settings

https://molecular.roche.com/news/roche-hiv-global-access-program-expands-to-include-next-generation-automated-platform-solutions/

Roche News |HIV Global Access Program expands High throughput cobas® systems help optimize workflow for resource-limited settings Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the expansion...

http://molecular.roche.com/News/LocalNews/Pages/Roche-Receives-FDA-Approval-for-Use-of-SurePath-Preservative-Fluid-with-cobas-HPV-Test.aspx

Roche Receives FDA Approval for Use of SurePath Preservative Fluid with cobas HPV Test for... Roche announced that the FDA approved the cobas® HPV Test for use as a first-line primary screening test for cervical cancer in women 25 and older.

http://molecular.roche.com/News/LocalNews/Pages/FDA-approved-CMV-test-for-use-in-hematopoietic-stem-cell-transplant.aspx

Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant... Roche today announced the United States Food and Drug Administration (FDA) approval of the first cytomegalovirus (CMV) test for use in hematopoietic stem cell transplant recipients.